An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a clinical trial.

Researchers mapped more than 11,000 transcriptomes across mice, rats, macaques, and humans, revealing conserved molecular ...

A molecule once thought to be a harmful metabolic byproduct may play a crucial role in early development and gene regulation, ...

Treatments aim to bulk up failing hearts to restore their vigour – but can the field move on from past controversy?

Tweaked lipid nanoparticle delivery system showed early safety ...

Eli Lilly is laying the groundwork for a phase 2 trial of the lipid-lowering gene editor it acquired from Verve Therapeutics, with the candidate now showing strong and consistent cholesterol ...

Dive into the opening of The Selfish Gene's first chapter 'Why are people?', the New Scientist Book Club’s read for June to mark 50 years since the popular science classic was first published ...

Editing your genes to eliminate bad cholesterol and a new discovery that could change the playbook for Alzheimer's. Here are ...

A powerful molecular clock calibrated using data on gene activity from thousands of individuals can predicts biological ...

What Is the MTHFR Gene Mutation? The MTHFR gene mutation is a variation in the MTHFR gene. This gene normally tells your body how to make the MTHFR protein. You need this protein to process folate, ...